High N-Terminal proB-Type Natriuretic Peptide Indicates Elevated Risk of Death after Percutaneous Coronary

Christian Roth1, Matthias Schneider2, Daniel Dalos3

  • 1Department of Internal Medicine II, Cardiology, Medical University of Vienna, 1090 Vienna, Austria. christian.roth@meduniwien.ac.at.

Insights

Coronary revascularization outcomes differ based on NT-proBNP levels. Elevated NT-proBNP indicates higher death risk with percutaneous coronary intervention (PCI) compared to coronary artery bypass grafting (CABG).

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Biomarkers

Background:

  • Reduced left ventricular function (LVF) is linked to stent thrombosis.
  • High NT-proBNP levels in advanced heart failure may increase coronary events with percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG).

Purpose of the Study:

  • To compare survival benefits of CABG versus PCI in patients with reduced LVF.
  • To determine if NT-proBNP predicts survival benefits after coronary revascularization.

Main Methods:

  • Observational retrospective study using data from the Medical University of Vienna.
  • Multivariate Cox regression analyses to assess the interaction between NT-proBNP levels and revascularization procedure on mortality risk.
  • Calculated relative risk of PCI versus CABG for low and elevated NT-proBNP groups.

Main Results:

  • The revascularization procedure alone did not predict survival in the overall population.
  • The interaction between revascularization procedure and NT-proBNP was an independent predictor of death.
  • PCI showed a similar risk to CABG in patients with low NT-proBNP, but a significantly increased risk in those with elevated NT-proBNP.

Conclusions:

  • Death risk associated with revascularization is significant only in patients with elevated NT-proBNP.
  • NT-proBNP is a predictive factor for revascularization outcomes.
  • Elevated NT-proBNP levels increase mortality risk after PCI compared to CABG; lower levels show similar risks for both procedures.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
912
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
390
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
222
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
342
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
606
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
6.8K